SEGMENT INFORMATION (Tables)

3 Months Ended

Dec. 29, 2017

Segment Reporting [Abstract]

Operating Results Information for Each Business Segment

The following table summarizes select operating results information for each reportable segment:

	Three Months Ended
(In millions)	December 29, 2017			December 30, 2016
Revenues
Oncology Systems	$	649.4		$	571.2
Varian Particle Therapy	29.1			30.3
Total Company	$	678.5		$	601.5
Operating Earnings
Oncology Systems	$	138.2		$	116.1
Varian Particle Therapy	(15.2		)	(50.3		)
Total reportable segments	123.0			65.8
Unallocated corporate	(1.6		)	(48.4		)
Total Company	$	121.4		$	17.4

Schedule of Disaggregation of Revenue

The Company disaggregates its revenues from contracts by major product categories and by geographic region for each of its reportable operating segments, as the Company believes this best depicts how the nature, amount, and timing an uncertainty of revenues and cash flows are affected by economic factors. See details in the tables below.

Total Revenues by product type	Three Months Ended December 29, 2017
(In millions)	Oncology		VPT		Total
Hardware	$	293.1	$	27.3	$	320.4
Software (1)	115.1		—		115.1
Service	241.2		1.8		243.0
Total Revenues	$	649.4	$	29.1	$	678.5

⁽¹⁾ Includes software support agreements that are recorded in revenues from service in the Condensed Consolidated Statements of Earnings (Loss).

Total Revenues by product type	Three Months Ended December 30, 2016
(In millions)	Oncology		VPT		Total
Hardware	$	238.6	$	26.8	$	265.4
Software (1)	112.2		—		112.2
Service	220.4		3.5		223.9
Total Revenues	$	571.2	$	30.3	$	601.5

⁽¹⁾  Includes software support agreements that are recorded in revenues from service in the Condensed Consolidated Statements of Earnings (Loss).

Total Revenues by geographical region	Three Months Ended December 29, 2017
(In millions)	Oncology		VPT		Total
Americas	$	337.4	$	19.3	$	356.7
EMEA	183.5		9.5		193.0
APAC	128.5		0.3		128.8
Total Revenues	$	649.4	$	29.1	$	678.5
North America	$	326.3	$	19.3	$	345.6
International	323.1		9.8		332.9
Total Revenues	$	649.4	$	29.1	$	678.5

Total Revenues by geographical region	Three Months Ended December 30, 2016
(In millions)	Oncology		VPT		Total
Americas	$	290.8	$	7.4	$	298.2
EMEA	169.0		15.0		184.0
APAC	111.4		7.9		119.3
Total Revenues	$	571.2	$	30.3	$	601.5
North America	$	275.0	$	7.4	$	282.4
International	296.2		22.9		319.1
Total Revenues	$	571.2	$	30.3	$	601.5

Timing of revenue recognition	Three Months Ended December 29, 2017
(In millions)	Products transferred at a point in time		Products and Services transferred over time		Total
Oncology Systems	$	338.3	$	311.1	$	649.4
VPT	—		29.1		29.1
Total Revenues	$	338.3	$	340.2	$	678.5

Timing of revenue recognition	Three Months Ended December 30, 2016
(In millions)	Products Transferred at a Point in Time		Products and Services Transferred Over Time		Total
Oncology Systems	$	282.4	$	288.8	$	571.2
VPT	—		30.3		30.3
Total Revenues	$	282.4	$	319.1	$	601.5